Group 1 - The core viewpoint of the article is the launch of the medical caregiver service supervision platform at Nankishan Hospital in Guangxi, which aims to address the challenges of "one person hospitalized, the whole family busy" by providing professional and standardized care without the need for family accompaniment [1] - The platform adopts a "reservation-management-training-service" closed-loop management model, covering four key user groups: hospitals, caregiver agencies, caregivers, and patients, ensuring more professional, standardized, and safe services [1] - The hospital focuses on patient needs and utilizes digital tools to enhance the nursing service experience, allowing patients to enjoy safer and more attentive care while relieving family members from the burden of accompaniment [1] Group 2 - Patients or family members can make appointments through the hospital's public account or mini-program, with a straightforward process that includes entering the mini-program, filling out appointment information, and submitting the order [2] - After submitting the appointment, the caregiver agency will contact the patient to confirm and generate a formal order, with order status updates available for easy tracking [3] - The appointment service process concludes with the ability to file complaints and provide satisfaction ratings for completed orders, ensuring feedback is collected for service improvement [4]

Core Viewpoint - The collaboration between the police and medical professionals in Ruoqiang County aims to enhance the health and well-being of law enforcement personnel, thereby strengthening public safety and community health [1][2]. Group 1: Event Overview - The Ruoqiang County Public Security Bureau and the local hospital organized a health service event titled "Salute to Police Day," providing free medical consultations to police officers [1]. - The initiative is part of a broader effort to show appreciation for police work and to address their health needs, particularly in light of the stresses associated with their duties [1]. Group 2: Health Services Provided - Medical staff conducted various health checks, including blood sugar and blood pressure measurements, and provided personalized health advice tailored to the specific challenges faced by police officers [1]. - The event included specialized services such as the application of "San Jiu" patches for joint and back pain, which are common issues among officers due to their demanding work schedules [1]. Group 3: Future Initiatives - The Ruoqiang County Public Security Bureau plans to continue and expand the collaboration with medical professionals to further support the health of police personnel and enhance their operational effectiveness [2]. - There is an emphasis on the importance of balancing work and health, encouraging officers to adopt healthier lifestyles to maintain their well-being while serving the community [2].

Core Viewpoint - WuXi AppTec (603259.SH) expects to achieve a net profit attributable to shareholders of approximately RMB 19.151 billion in 2025, representing a year-on-year growth of about 102.65% [1] Group 1: Business Model and Strategy - The company continues to focus on its unique "integrated, end-to-end" CRDMO (Contract Research, Development, and Manufacturing Organization) business model [1] - It is committed to meeting customer demands for empowerment and is continuously expanding new capabilities and building new production capacity [1] - The company aims to optimize production processes and improve operational efficiency to drive steady business growth [1] Group 2: Commitment to Clients and Market - WuXi AppTec is dedicated to empowering clients efficiently and aims to bring more new and effective drugs to patients worldwide [1]

来源：市场资讯 有投资者在互动平台向通策医疗提问："请问截止2026年1月10日公司的股东数是多少？" 针对上述提问，通策医疗回应称："您好，截至2026年1月10日公司股东总数为9万多。为确保所有投资 者能公平地获取信息，相关股东人数信息后续请以公司正式披露的定期报告为准，感谢您的关注。" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 ...

证券之星消息，1月12日医疗服务板块较上一交易日上涨1.96%，迪安诊断领涨。当日上证指数报收于 4165.29，上涨1.09%。深证成指报收于14366.91，上涨1.75%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | --- | | 300244 | 迪安诊断 | 26.06 | 19.98% | | 53.35万 | | 13.76亿 | | 920670 | 数字人 | 21.21 | 16.03% | | 17.81万 | | 3.59亿 | | 300149 | 睿智医药 | 12.61 | 15.16% | | 81.36万 | | 10.15 乙 | | 688796 | 百奥赛图 | 68.68 | 14.87% | | 6.44万 | | 4.25亿 | | 301230 | 泓博医药 | 47.30 | 14.69% | | 32.66万 | | 15.01亿 | | 688222 | 成都先导 | 37.00 | 13.7 ...

Market Performance - The Hong Kong stock market indices strengthened collectively, with the Hang Seng Index rising by 1.44% to 26,608.48 points, the Tech Index increasing by 3.10% to 5,863.20 points, and the National Enterprises Index up by 1.90% to 9,220.08 points [2]. Sector Highlights - The leading sectors included internet technology, AI applications, SaaS concepts, AI healthcare, paper industry, film and entertainment, and commercial aerospace, while pharmaceutical research services and lithium battery sectors experienced a pullback [5]. AI and Technology Sector - Major internet companies showed strong performance, with Alibaba Health rising by 10.23%, Kuaishou by 7.43%, and Meituan by 6.60% [6]. - The rise in AI applications was notable, with stocks like Zhiyun (31.40% increase) and Weimeng Group (21.39% increase) leading the charge [8]. Paper Industry - The paper sector saw gains due to improved supply-demand dynamics and favorable exchange rates, with Nine Dragons Paper up by 10.06% and Lee & Man Paper by 5.81% [12]. Film and Entertainment Sector - The film sector benefited from rising expectations for the upcoming Spring Festival box office, with stocks like Damai Entertainment increasing by 6.98% and Maoyan Entertainment by 3.86% [14]. Commercial Aerospace - Stocks in the commercial aerospace sector rose due to policy benefits, with Asia Pacific Satellite increasing by 18.16% [16]. Pharmaceutical Sector - The pharmaceutical sector showed mixed results, with stocks like Zhaoyan New Drug down by 4.29% while the healthcare index overall rose by 10.3% in the first week of 2026 [18]. Lithium Battery Sector - The lithium battery sector faced pressure from policy adjustments, with stocks like CATL down by 2.45% following the announcement of changes to export tax rates [20]. Individual Stock Movements - Tongcheng Travel saw a rise of 5.61% due to increased demand for off-peak travel as students enter their winter break [22]. - Bilibili increased by 6.54% as AI technology improved marketing material production efficiency and advertising effectiveness [23].

药明康德公告称，预计2025年实现营业收入约454.56亿元，同比增长15.84%，其中持续经营业务收入同 比增21.40%；经调整归母净利润约149.57亿元，同比增长41.33%；扣非净利润约132.41亿元，同比增长 32.56%；归母净利润约191.51亿元，同比增长102.65%；基本每股收益约6.70元/股，同比增长 104.27%。业绩增长因公司聚焦CRDMO业务模式，且非经常性损益包括出售股权等净收益约55.95亿 元。 ...

智通财经APP获悉，浙商证券发布研报称，AI医疗应用在国家战略与市场需求的共振下已迈入商业化落 地的快速阶段。该行认为AI制药核心价值在于大幅提升药物早研效率，看好国内多家AI制药平台服务 能力全球领先。AI制药的高需求将带来较大的落地验证实验及合作需求，建议关注已与AI制药平台有 战略合作的传统CRO公司。此外，早研效率大幅提升将快速传导至临床前、安评以及临床CRO需求。 浙商证券主要观点如下： 该行认为AI制药核心价值在于大幅提升药物早研效率，以英矽智能Pharma.AI为例，其能够使候选药物 从靶点发现到临床前候选药物确认时间从4.5年大幅缩短到12至18个月，早研阶段的投入产出比大幅提 升。该行看好：1)国内多家AI制药平台服务能力全球领先，海外业务拓展持续高速已验证，关注英矽智 能、晶泰科技、泓博医药、维亚生物、成都先导等;2)AI制药的高需求将带来较大的落地验证实验及合 作需求，建议关注已与AI制药平台有战略合作的传统CRO公司，关注皓元医药、美迪西、百诚医药、 阳光诺和、药石科技、药明康德等;3)早研效率大幅提升将快速传导至临床前、安评以及临床CRO需 求，建议关注昭衍新药、美迪西、益诺思、泰格 ...

智通财经APP讯，合富中国(603122.SH)发布公告，公司2025年1-12月合并营业收入人民币6.89亿元，较 去年同期下降26.67%。 ...

1月12日，医疗ETF（159828）盘中涨超2%，政策周期与行业复苏或成关键驱动。 平安证券指出，泛RAS/KRAS抑制剂的开发可覆盖更多突变类型且有望克服耐药问题，其中KRAS是人 类癌症突变的主要基因（81%）。Revolution的泛RAS抑制剂RMC-6236在临床1期中显示出对胰腺导管 癌患者的有效性和可控安全性，目前处于3期临床阶段。CXO和上游领域，医药融资小幅增长，BD交易 和H股IPO回暖激活创新热情，订单端呈现回暖态势，外向型CXO需求增长，内向型CXO订单回暖，建 议关注SMO、临床前CRO等领域。器械行业短期受政策影响承压，但随着反内卷政策出台、集采出清 及企业创新升级和国际业务拓展，基本面有望改善。 （文章来源：每日经济新闻） 医疗ETF（159828）跟踪的是中证医疗指数（399989），该指数从A股市场中选取涉及医疗器械、医疗 服务、医疗信息化等领域的上市公司证券作为指数样本，以反映中国医疗主题上市公司的整体表现。中 证医疗指数成分股数量约50只，行业配置集中于医药卫生领域。 ...